La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F, Decarli A
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Int J Cancer. 1994 Dec 15;59(6):761-4. doi: 10.1002/ijc.2910590609.
To understand possible correlates of the systematically higher gastric-cancer rates in males than in females, we investigated the role of menstrual, reproductive and hormonal factors in females, using data from a case-control study conducted in Northern Italy. Cases were 229 post-menopausal women with incident, histologically confirmed gastric cancer, and controls were 614 post-menopausal women in hospital for acute, non-neoplastic, non-digestive-tract conditions. After allowance for age, education, family history, and selected dietary correlates of stomach cancer, a reduced gastric-cancer risk was observed in women with later menopause (odds ratio, OR = 0.6, p value for trend < 0.05), and longer duration of fertile life (OR = 0.7, but the trend in risk was not significant). The risk of gastric cancer was elevated in multiparous women (OR = 1.7 for 3 and 1.9 for > or = 4 births as compared to nulliparae). No association was observed with age at menarche, age at first birth, and with number of spontaneous or induced abortions. Ever-users of oral contraceptives had a non-significant increased risk (OR = 1.3), and users of oestrogen-replacement treatment a non-significant reduced risk (OR = 0.5). Although the association with each factor was moderate, and the interpretation of these findings is not straightforward, these results are compatible with the hypothesis that some role is played by (endogenous and exogenous) female hormones in the process of gastric carcinogenesis.
为了解男性胃癌发病率系统性高于女性的可能相关因素,我们利用在意大利北部开展的一项病例对照研究的数据,调查了女性月经、生殖和激素因素的作用。病例为229名绝经后新发组织学确诊胃癌的女性,对照为614名因急性非肿瘤性非消化道疾病住院的绝经后女性。在考虑年龄、教育程度、家族史以及选定的胃癌饮食相关因素后,观察到绝经较晚的女性患胃癌风险降低(比值比,OR = 0.6,趋势p值 < 0.05),以及生育期较长的女性患胃癌风险降低(OR = 0.7,但风险趋势不显著)。经产妇患胃癌的风险升高(与未生育女性相比,生育3次的OR = 1.7,生育≥4次的OR = 1.9)。未观察到初潮年龄、首次生育年龄以及自然流产或人工流产次数与胃癌风险之间存在关联。曾经使用口服避孕药的女性患胃癌风险有非显著性升高(OR = 1.3),使用雌激素替代治疗的女性患胃癌风险有非显著性降低(OR = 0.5)。尽管与每个因素的关联程度中等,且这些研究结果的解读并不简单直接,但这些结果与(内源性和外源性)女性激素在胃癌发生过程中发挥某种作用的假设相符。